rs77120160
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BA1BS3
This summary comes from the ClinGen Evidence Repository: NM_000249.4(MLH1):c.1732-19T>A is an intronic variant for which the gnomAD filtering allele frequency (African/African American) is 2.8% and gnomAD v4.1 Grpmax AF is 2.898%, meeting BA1 criteria according to the Maximum Credible Allele Frequency (MCAF) cutoffs for MLH1. There was also no impact on splicing in laboratory assays using nonsense-mediated decay inhibition (PMID:27629256). In summary, this variant meets the criteria to be classified as benign for Lynch Syndrome, based on the MMR gene specific ACMG/AMP criteria established by the ClinGen InSiGHT Hereditary Colorectal Cancer/ Polyposis VCEP: BA1 and BS3 (VCEP specifications version 1) LINK:https://erepo.genome.network/evrepo/ui/classification/CA006607/MONDO:0007356/115
Frequency
Consequence
NM_000249.4 intron
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | TSL:1 MANE Select | c.1732-19T>A | intron | N/A | ENSP00000231790.3 | P40692-1 | |||
| MLH1 | TSL:1 | c.1732-19T>A | intron | N/A | ENSP00000416687.3 | H0Y818 | |||
| MLH1 | TSL:1 | c.1668-2986T>A | intron | N/A | ENSP00000416476.2 | H0Y806 |
Frequencies
GnomAD3 genomes AF: 0.00914 AC: 1391AN: 152192Hom.: 25 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00214 AC: 538AN: 251116 AF XY: 0.00153 show subpopulations
GnomAD4 exome AF: 0.000874 AC: 1277AN: 1461648Hom.: 20 Cov.: 31 AF XY: 0.000734 AC XY: 534AN XY: 727134 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00913 AC: 1391AN: 152310Hom.: 25 Cov.: 31 AF XY: 0.00920 AC XY: 685AN XY: 74476 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at